Cyclacel, Netlist: Early Volume Plays
NEW YORK (
) -- A handful of stocks trading near $5 were poised to move on above-average volume during Wednesday's regular session.
Cyclacel Pharmaceuticals
(CYCC) - Get Report
jumped 12.5% to $2.70 after the company announced that a newly published study in clinical cancer research demonstrates potential for Cyclacel's Seliciclib in treating breast cancer resistant to hormone therapy. Selicicli is currently in phase 2 clinical trials. The 50-day average daily volume for Cyclacel is 7.4 million shares.
Achillion Pharmaceuticals
(ACHN) - Get Report
rose 4.6% to $2.50 after the company announced additional positive safety and efficacy results from its Phase 2 trial studying elvucitabine in patients infected with HIV. The 50-day average daily volume for Achillion Pharmaceuticals is 893,000 shares.
Netlist
(NLST)
shot up 7.9% to $4.50 after it said it began volume shipments of its non-volatile cache memory product NetVault. The 50-day average daily volume for Netlist is 2.3 million shares.
TheStreet Recommends
Sequenom
(SQNM)
edged 0.4% lower to $5.20 after the company announced the launch of its SensiGene fetal sex determination test.The 50-day average daily volume for Sequenom is 3.5 million shares.
-- Reported by Andrea Tse in New York
Check out all of Tuesday's high-volume, under-$10 stocks at the
>>See our new stock quote page.
Follow TheStreet.com on
and become a fan on
Copyright 2009 TheStreet.com Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
